• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94703ED
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cytomegalovirus (CMV) Infection (2220)
Event Date 02/15/2021
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: botox®.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The events are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reported that a patient was injected in the lips and perioral lines with 1 ml of juvéderm® volift® with lidocaine.The patient was concomitantly injected in the glabella with botox®.The patient had ¿minimal bruising and pin-point bleeding¿ that was controlled at the injecting clinic.The patient was sent home with an ice pack and after care instructions.The patient later developed ¿swelling and tenderness¿ in the lips, ¿nodules¿ under the oral commissures, and ¿ulcers inside the mouth due to swelling and them rubbing against [the] teeth." the health professional recommended the patient take oral antis, take antihistamines and antiviral and return for a review in one week to determine is hyalase is needed or not.The event is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLIFT WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key11802550
MDR Text Key249992070
Report Number3005113652-2021-00261
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Nurse
Type of Report Initial
Report Date 05/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue Number94703ED
Device Lot NumberV17LA90818
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-